USPTO serial 79302302
SYMPHONX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 7, 2022
- Examiner
- FLETCHER, TRACY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SYMPHONX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
FUJIFILM Diosynth Biotechnologies UK Limited
GB
Other trademarks owned by FUJIFILM Diosynth Biotechnologies UK Limited
FUJIFILM Diosynth Biotechnologies UK Limited
GB
Other trademarks owned by FUJIFILM Diosynth Biotechnologies UK Limited
FUJIFILM Diosynth Biotechnologies UK Limited
GB
Other trademarks owned by FUJIFILM Diosynth Biotechnologies UK Limited
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Fluid processing system for use in the separation and purification of biological products such as cells, viruses and biomolecules, including nucleic acids and proteins, for bioprocessing and pharmaceutical research, comprised primarily of chromatography apparatus for laboratory use, laboratory filters, and fluid handling devices used for bioprocessing applications and component parts and fittings; Liquid chromatography apparatus for laboratory use; Ion exchange chromatography apparatus for the treatment of fluids for laboratory use; Ultrafiltration apparatus for laboratory or scientific research use, namely, ultrafiltration laboratory filters and laboratory ultrafiltration filter membranes as part of scientific apparatus; Diafiltration apparatus for laboratory or scientific research use, namely, laboratory diafiltration filters; Scientific, laboratory, and measuring apparatus and instruments for diluting or concentrating biological products for laboratory or scientific research use, namely, tangential flow filtration devices for preparation of biological samples for use in the biopharmaceutical industry; Laboratory filters in the nature of viral filtration apparatus for removal of viruses from solutions for laboratory or scientific research use; Membrane filtration apparatus in the nature of membrane laboratory filters for use in laboratory equipment in the biopharmaceutical industry for treating biological fluids and solutions; Chromatography apparatus and component parts thereof for laboratory or scientific research use; Parts and fittings, namely, tubing, valves, in-line mixers, pressure sensors, temperature sensors and electronic sensors specially adapted for use with all of the aforementioned goods; Computer software for control of the aforesaid goods, namely, downloadable and recorded software for operating a fluid processing apparatus for laboratory or scientific research use comprising chromatography, membrane filtration, tangential flow filtration, viral filtration, ultrafiltration, diafiltration, viral filtration, viral inactivation, in-line conditioning, and buffer management components and systems; Computer software for management of biological product purification processes, namely, downloadable and recorded software for managing the purification of cells, viruses, and biomolecules in the nature of nucleic acids and proteins | ACTIVE | — |
| 011 | Fluid processing system apparatus and system for use in the separation and purification of biological products such as cells, viruses and biomolecules, including nucleic acids and proteins, for the pharmaceutical and biomanufacturing industries, namely, chromatography apparatus for industrial use and apparatus and instruments for use in the purification, conditioning, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Liquid chromatography apparatus for industrial purposes; Ion exchange apparatus for the treatment of fluids for industrial purposes; Ultrafiltration apparatus for industrial purposes, namely, apparatus and instruments for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Diafiltration apparatus, namely, aqueous solution filtering systems and components and biological fluid filtering systems and components for industrial purposes being apparatus and instruments for use in the purification, separation and sterilization of liquids used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Apparatus for diluting or concentrating biological products for industrial purposes, namely, tangential flow filtration apparatus being apparatus for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Viral filtration apparatus for removal of viruses from solutions for industrial purposes, namely, apparatus and instruments for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Virus inactivation and disinfection apparatus for the treatment of biological products in the field of biomanufacturing and pharmaceuticals, all for industrial purposes in the nature of apparatus and instruments for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Membrane filtration apparatus for industrial purposes in the nature of membrane filter cartridges for the separation of biomolecules in biopharmaceutical production; Chromatography apparatus for industrial purposes and component parts thereof; Parts and fittings, namely, tubing, valves, in-line mixers, pressure sensors, temperature sensors and electric sensors, specially adapted for use with the aforementioned | ACTIVE | — |
| 040 | Processing and manufacturing of biological products such as cells, viruses and biomolecules, including genes and proteins, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process to the order and specification of others; Manufacture of biomolecules such as cells, viruses and biomolecules, including genes and proteins, to the order and specification of others | ACTIVE | — |
| 042 | Scientific research, industrial biomedical research and technical product research and development services in the field of biomanufacturing, bioprocessing and pharmaceuticals related to biological products such as cells, viruses and biomolecules, including nucleic acids and proteins; Process development services related to the manufacture and purification of biological products such as such as cells, viruses and biomolecules, including nucleic acids and proteins, namely, biomedical and pharmaceutical research; Industrial design services related to the manufacture and purification of biological products such as cells, viruses and biomolecules, including nucleic acids and proteins; Provision of facilities for scientific, industrial and technical research and development in the field of biomanufacturing, bioprocessing and pharmaceuticals, namely, scientific laboratory services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by FUJIFILM Diosynth Biotechnologies UK Limited
- Other trademarks owned by FUJIFILM Diosynth Biotechnologies UK Limited
- Other trademarks owned by FUJIFILM Diosynth Biotechnologies UK Limited
- Other trademarks in Class 009
- Other trademarks in Class 011
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named SYMPHONX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 16, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 25, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 19, 2022 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Sep 19, 2022 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Sep 7, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 7, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 7, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 27, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 22, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 22, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 2, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 2, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 2, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 14, 2022 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 14, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 14, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 13, 2022 | ALIE | ASSIGNED TO LIE | — |
| Feb 11, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 11, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 11, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 23, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 23, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 23, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 5, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 1, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 5, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 5, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 21, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 20, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 19, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 15, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 15, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 14, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |